Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 498,159
  • Shares Outstanding, K 44,007
  • Annual Sales, $ 3,730 K
  • Annual Income, $ -142,570 K
  • 60-Month Beta 0.90
  • Price/Sales 128.16
  • Price/Cash Flow N/A
  • Price/Book 2.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.86
  • Number of Estimates 5
  • High Estimate -0.80
  • Low Estimate -0.97
  • Prior Year -0.94
  • Growth Rate Est. (year over year) +8.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.37 +10.80%
on 06/07/19
12.14 -5.35%
on 05/24/19
-0.41 (-3.45%)
since 05/17/19
3-Month
10.37 +10.80%
on 06/07/19
16.49 -30.32%
on 03/19/19
-4.51 (-28.19%)
since 03/18/19
52-Week
10.37 +10.80%
on 06/07/19
31.65 -63.70%
on 06/20/18
-19.16 (-62.51%)
since 06/18/18

Most Recent Stories

More News
Shares of RVNC Down 36.6% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Revance Therapeu (NASDAQ:RVNC) on January 17th, 2019 at $17.33. In approximately 5 months, Revance Therapeu has returned 36.57% as of today's recent price of $10.99....

RVNC : 11.49 (+1.50%)
Revance Adds Iconic Brand Builder Jill Beraud to Board of Directors

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing a new category of high-performance neuromodulators for use in treating aesthetic and therapeutic conditions,...

LVISF : 11.2600 (-2.17%)
RVNC : 11.49 (+1.50%)
Revance to Participate in the Goldman Sachs 40th Annual Global Healthcare Conference

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that...

RVNC : 11.49 (+1.50%)
Downtrend Call Working As Revance Therapeu Stock Falls 34.6% (RVNC)

SmarTrend identified a Downtrend for Revance Therapeu (NASDAQ:RVNC) on January 17th, 2019 at $17.33. In approximately 4 months, Revance Therapeu has returned 34.60% as of today's recent price of $11.33....

RVNC : 11.49 (+1.50%)
Shares of Intra-Cellular T Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (ITCI , RVNC , AERI , NKTR , DERM )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

ITCI : 13.91 (-1.70%)
AERI : 33.84 (+1.65%)
RVNC : 11.49 (+1.50%)
Revance to Participate in the RBC Capital Markets 2019 Healthcare Conference

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that...

RVNC : 11.49 (+1.50%)
Revance Therapeu Has Returned 26.5% Since SmarTrend Recommendation (RVNC)

SmarTrend identified a Downtrend for Revance Therapeu (NASDAQ:RVNC) on January 17th, 2019 at $17.33. In approximately 4 months, Revance Therapeu has returned 26.52% as of today's recent price of $12.73....

RVNC : 11.49 (+1.50%)
Revance Reports First Quarter 2019 Financial Results and Provides Corporate Update

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today reported financial...

RVNC : 11.49 (+1.50%)
Revance Therapeu Shares Down 23.2% Since SmarTrend's Sell Call (RVNC)

SmarTrend identified a Downtrend for Revance Therapeu (NASDAQ:RVNC) on January 17th, 2019 at $17.33. In approximately 3 months, Revance Therapeu has returned 23.23% as of today's recent price of $13.30....

RVNC : 11.49 (+1.50%)
Revance Therapeu Has Returned 20.3% Since SmarTrend Recommendation (RVNC)

SmarTrend identified a Downtrend for Revance Therapeu (NASDAQ:RVNC) on January 17th, 2019 at $17.33. In approximately 3 months, Revance Therapeu has returned 20.29% as of today's recent price of $13.81....

RVNC : 11.49 (+1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade RVNC with:

Business Summary

Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance's science is based upon a proprietary TransMTS' peptide technology, which when combined...

See More

Key Turning Points

2nd Resistance Point 11.91
1st Resistance Point 11.70
Last Price 11.49
1st Support Level 11.30
2nd Support Level 11.11

See More

52-Week High 31.65
Fibonacci 61.8% 23.52
Fibonacci 50% 21.01
Fibonacci 38.2% 18.50
Last Price 11.49
52-Week Low 10.37

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar